인기 연구 키워드 :
인기 활용 키워드 :

Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발

최우식 2021년

활용도
공유도
영향력

논문상세정보

- 저자 최우식
- 형태사항 26 cm: xiii, 147p
- 일반주기 지도교수: 서주원
- 학위논문사항 2021. 2, 학위논문(박사)-, 명지대학교 대학원, 바이오모듈레이션학학과간협동과정
- 발행지 서울
- 언어 eng
- 출판년 2021
- 발행사항 명지대학교 대학원
- 주제어 Abnormal signaling Anticancer material Receptor tyrosine kinase Cancer therapy Epithelialgrowthfactorreceptor nano structure
- 참고문헌( 134)
유사주제 논문( 124)

인용/피인용

Development of Novel Antibody-DNA Nanostructur ...

' Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발' 의 주제별 논문영향력

논문영향력 요약
동일주제 총논문수	논문피인용 총횟수	주제별 논문영향력의 평균
주제	Abnormal signaling Anticancer material Receptor tyrosine kinase cancer therapy epithelialgrowthfactorreceptor nano structure
130	0	0.0%

논문영향력
주제		주제별 논문수	주제별 논문영향력
주제어	Abnormal signaling	1	0.0%
	Anticancer material	1	0.0%
	Receptor tyrosine kinase	6	0.0%
	cancer therapy	43	0.0%
	epithelialgrowthfactorrecepto ...	2	0.0%
	nano structure	77	0.0%
계		130	0.0%
* 다른 주제어 보유 논문에서 피인용된 횟수

' Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발' 의 참고문헌

p38 MAP-Kinases pathway regulation , function and role in human diseases
Cuenda A.Simon Rousseau Biochimica et biophysica acta . Molecular cell research . 1773:1358-1375. doi : 10.1016/j.bbamcr.2007.03.010 [2007]
mTOR inhibitors in cancer therapy
Zaytseva Y. Y.Joseph D. ValentinoPat GulhatiB . Mark Evers Cancer letters319:1-7. doi : 10.1016/j.canlet.2012.01.005 [2012]
Wu E., Nathan Palmer, Ze Tian, Annie P. Moseman, Michal Galdzicki, Xuetao Wang, Bonnie Berger, Hongbing Zhang and Isaac S. Kohane. (2008) Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells. PloS one. 3:e3794. doi: 10.1371/journal.pone.0003794
Wu E.Nathan PalmerZe TianAnnie P. MosemanMichal GaldzickiXuetao WangBonnie BergerHongbing ZhangIsaac S. Kohane PloS one3 : e3794 . doi : 10.1371/journal.pone.0003794 [2008]
Wang W., Laura M. Nocka, Brianne Z. Wiemann, Daniel M. Hinckley, Ishita Mukerji and Francis W. Starr. (2016) Holliday Junction Thermodynamics and Structure: Coarse?Grained Simulations and Experiments. Scientific reports. 6:22863. doi: 10.1038/srep22863
Wang S., Shundong Cang and Delong Liu. (2016) Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer. Journal of hematology and oncology. 9:34. doi: 10.1186/s13045-016-0268-z
Wang S.Shundong CangDelong Liu Journal of hematology and oncology9:34. doi : 10.1186/s13045-016-0268-z [2016]
Wagner E. F. and Ángel R. Nebreda. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nature reviews. Cancer. 9:537-549. doi: 10.1038/nrc2694
Wagner E. F.ngel R. Nebreda Nature reviews . Cancer9:537-549. doi : 10.1038/nrc2694 [2009]
W. Pao , E. McKinely ,
J. T. ,G. OlivaresC. RinehartN. D., V. SanchezA. ChakrabartyB. DaveR. S. Cook ) compensates for inhibition of the HER2 tyrosine kinase . Proceedings of the National [Manning]
Vieira A. V., Christophe Lamaze and Sandra L. Schmid. (1996) Control of EGF Receptor Signaling by Clathrin-Mediated Endocytosis. Science. 274:2086-2089. doi: 10.1126/science.274.5295.2086
A. V.Christophe LamazeSandra L. Schmid Science . 274:2086-2089. doi : 10.1126/science.274.5295.2086 [1996]
Vascular endothelial growth factor ( VEGF ) inducerad angiogenes i skelettmuskulatur vid akut och kronisk hypoxi
Nilsson F. Publikationer fr ? n ? rebro universitet . Noble M. E. M.Science ( American Association for the Advancement of Science ) . 303:1800- 1805. doi : 10.1126/science.1095920 [20112004]
VEGF-null cells require PDGFR α signaling-mediated stromal fibroblast recruitment for tumorigenesis
Dong J.Jeremy GrunsteinMax TejadaFrank PealeGretchen FrantzWei-Ching LiangWei BaiLanlan YuJoe KowalskiXiaohuan LiangGermaine FuhHans-Peter GerberNapoleone Ferrara The EMBO journal23:2800-2810. doi : 10.1038/sj.emboj.7600289 [2004]
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
Liao B.Chia-Chi LinJih-Hsiang LeeJames Chih-Hsin Yang Journal of biomedical science . 23:86. doi : 10.1186/s12929-016-0305-9 [2016]
Tørring T., Niels V. Voigt, Jeanette Nangreave, Hao Yan and Kurt V. Gothelf. (2011) DNA origami: a quantum leap for self-assembly of complex structures. Chemical Society reviews. 40:5636-5646. doi: 10.1039/c1cs15057j
Tørring T.Niels V. VoigtJeanette NangreaveHao YanKurt V. Gothelf Chemical Society reviews40:5636-5646. doi : 10.1039/c1cs15057j [2011]
Tyrosine kinase ? Role and significance in Cancer
Paul M. K.Anup K. Mukhopadhyay International journal of medical sciences1:101-115. doi : 10.7150/ijms.1.101 [2004]
Turke A. B., Kreshnik Zejnullahu, Yi-Long Wu, Youngchul Song, Dora Dias-Santagata, Eugene Lifshits, Luca Toschi, Andrew Rogers, Tony Mok, Lecia Sequist, Neal I.
Turke A . B.Kreshnik ZejnullahuYi-Long WuYoungchul SongDora Dias-SantagataEugene LifshitsLuca ToschiAndrew RogersTony MokLecia Sequist [Neal I]
Trastuzumab—mechanism of action and use in clinical practice
Hudis CA The New England Journal of Medicine . 357:39-51. doi : 10.1056/NEJMra043186 [2007]
The protein tyrosine kinase family of the human genome
Robinson D. R.Yi-Mi WuSu-Fang Lin Oncogene . 19:5548-5557. doi : 10.1038/sj.onc.1203957 [2000]
The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily
Aroian R. V.Yasumi OhshimaMakoto KogaPaul W. SternbergJane E. Mendel Nature348:693-699. doi : 10.1038/348693a0 [1990]
The enabled state of DNA nanotechnology
Linko V.Hendrik Dietz Current opinion in biotechnology . 24:555-561. doi : 10.1016/j.copbio.2013.02.001 [2013]
The MAPK ERK5 , but not ERK1/2 , inhibits the progression of monocytic phenotype to the functioning macrophage
Wang X.Stella PesakhovJonathan S. HarrisonMichael KafkaMichael DanilenkoGeorge P. Studzinski Experimental cell research330:199-211. doi : 10.1016/j.yexcr.2014.10.003 [2015]
The Insulin Receptor : A New Target for Cancer Therapy
Malaguarnera R.Antonino Belfiore Frontiers in endocrinology ( Lausanne ) . 2:93. doi : 10.3389/fendo.2011.00093 [2011]
The IRS-signalling system : A network of docking proteins that mediate insulin action
White M. Mol Cell Biochem182:3-11. doi : 10.1023/A:1006806722619 [1998]
Targeting the MAPK ? RAS ? RAF signaling pathway in cancer therapy
Santarpia L.Scott M. LippmanAdel K. El-Naggar Expert opinion on therapeutic targets . 16:103-119. doi : 10.1517/14728222.2011.645805 [2012]
Targeting RTK Signaling Pathways in Cancer
Regad T. Cancers . 7:1758-1784. doi : 10.3390/cancers7030860 [2015]
Targeting PI3K signalling in cancer : opportunities , challenges and limitations
Engelman J . A . Nature reviewsCancer . 9:550-562. doi : 10.1038/nrc2664 Ferguson E. L. and H. Robert Horvitz . ( 1985 ) IDENTIFICATION AND CHARACTERIZATION OF 22 GENES THAT AFFECT THE VULVAL CELL LINEAGES OF THE NEMATODE CAENORHABDITIS ELEGANS . Genetics . 110:17- 72 [2009]
Takeuchi K. and Fumiaki Ito. (2011) Receptor Tyrosine Kinases and Targeted Cancer Therapeutics. Biological & pharmaceutical bulletin. 34:1774-1780. doi: 10.1248/bpb.34.1774
Takeuchi K.Fumiaki Ito Biological & pharmaceutical bulletin . 34:1774-1780. doi : 10.1248/bpb.34.1774 [2011]
T. H. LaBean and J. H. Reif
Yin P.R. F. HariadiS. SahuH. M. T. ChoiS. H. Park Science ( American Association for the Advancement of Science ) . 321:824-826. doi : 10.1126/science.1157312 [2008]
Structural aspects of oligomerization taking place between the transmembrane α-helices of bitopic membrane proteins
Arkin I. T. Biochimica et Biophysica Acta ( BBA ) - Biomembranes . 1565:347-363. doi : 10.1016/s0005-2736 ( 02 ) 00580-1 [2002]
Structural DNA Nanotechnology : From Design to Applications
Zadegan R. M.Michael L. Norton International journal of molecular sciences13:7149-7162. doi : 10.3390/ijms13067149 [2012]
Stephen Lyle
Jiang J.Alexei ProtopopovRuobai SunMeaghan Russell Journal of personalized medicine . 8:13. doi : 10.3390/jpm8020013 [2018]
Spatial regulation of receptor tyrosine kinases in development and cancer
Casaletto J . B.Andrea I. McClatchey . Nature reviews . Cancer12:387-400. doi : 10.1038/nrc3277
Spatial control of coated-pit dynamics in living cells
Santini F.Robin A. WarrenJames H. KeenIbragim Gaidarov Nature Cell Biology1:1-7. doi : 10.1038/8971 [1999]
Spatial control of EGF receptor activation by reversible dimerization on living cells
Chung I.Robert AkitaRichard VandlenDerek ToomreJoseph SchlessingerIra Mellman NatureLondon ) . 464:783-787. doi : 10.1038/nature08827 [2010]
Sorkin A. and Mark von Zastrow. (2009) Endocytosis and signalling: intertwining molecular networks. Nature reviews. Molecular cell biology. 10:609-622. doi: 10.1038/nrm2748
Sorkin A.Mark von Zastrow Nature reviews . Molecular cell biology10:609-622. doi : 10.1038/nrm2748 [2009]
Sobczak J. -. J., T. G. Martin, T. Gerling and H. Dietz. (2012) Rapid Folding of DNA into Nanoscale Shapes at Constant Temperature. Science (American Association for the Advancement of Science). 338:1458-1461. doi: 10.1126/science.1229919
Sobczak J . - . J.T. G. MartinT. GerlingH. Dietz Science ( American Association for the Advancement of Science ) . 338:1458-1461. doi : 10.1126/science.1229919 [2012]
Sakurai T., S. Maeda, L. Chang and M. Karin. (2006) Loss of hepatic NF- B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proceedings of the National Academy of Sciences - PNAS. 103:10544-10551. doi: 10.1073/pnas.0603499103
Sakurai T.S. MaedaL. ChangM. Karin Proceedings of the National Academy of Sciences - PNAS . 103:10544-10551. doi : 10.1073/pnas.0603499103 [2006]
Ronald Burkes , Mario Barugel , Yves Humblet? makal , Jean Luc Canon , Mark Rother ,
, KellyOliner ,SienaJosep TaberneroGyorgy Bodoky ,Cunningham ,Jassem ,Rivera ,Koc ?, Paul, Maria Błasi Williams , Alan Rong , Jeffrey Wiezorek , Roger Sidhu and [,]
Regulation of cellular functions by the ERK5 signalling pathway
Wang X.Cathy Tournier Cellular signalling18:753-760. doi : 10.1016/j.cellsig.2005.11.003 [2006]
Regulation of Raf through Phosphorylation and N Terminus-C Terminus Interaction
Huira ChongKun-Liang Guan Journal of Biological Chemistry278:36269-36276. doi : 10.1074/jbc.M212803200 [2003]
Properties of FDA-approved small molecule protein kinase inhibitors : A 2020 update
Roskoski R. Pharmacological research . 152:104609. doi : 10.1016/j.phrs.2019.104609 [2020]
Platelet-derived growth factors and their receptors : Structural and functional perspectives
Chen P.Xiaoyan ChenXiaolin He Biochimica et biophysica actaProteins and proteomics . 1834:2176-2186. doi : 10.1016/j.bbapap.2012.10.015 [2013]
Platelet-derived Growth Factor Receptor-mediated Signal Transduction from Endosomes
Yi WangSteven D. PennockXinmei ChenAndrius KazlauskasZhixiang Wang Journal of Biological Chemistry279:8038-8046. doi : 10.1074/jbc.M311494200 [2004]
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov DD Science ( American Association for the Advancement of Science ) . 307:1098- 1101. doi : 10.1126/science.1106148 [2005]
Philip A. Cole
Zhang X.Jodi GureaskoKui ShenJohn Kuriyan CellCambridge ) . 125:1137-1149. doi : 10.1016/j.cell.2006.05.013 [2006]
Peterson , Sandra Camelo-Piragua , Chris Jones
C. ,Zamler ,MacKay ,Robinson ,Wu ,Doherty ,Marini ,Tran ,Garton ,Muraszko ,Robertson ,Leonard ,Zhao ,Bixby , ) Characterizing and targeting PDGFRA alterations [Mody]
Peter Nagy, Jeroen Claus, Thomas M. Jovin and Donna J. Arndt-Jovin. (2010) Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. Proceedings of the National Academy of Sciences - PNAS. 107:16524-16529. doi: 10.1073/pnas.1002642107
Peter NagyJeroen ClausThomas M. JovinDonna J. Arndt-Jovin Proceedings of the National Academy of Sciences - PNAS . 107:16524-16529. doi : 10.1073/pnas.1002642107 [2010]
Patrick Lajoie, Jacky G. Goetz, James W. Dennis and Ivan R. Nabi. (2009) Lattices, Rafts, and Scaffolds: Domain Regulation of Receptor Signaling at the Plasma Membrane. The Journal of cell biology. 185:381-385. doi: 10.1083/jcb.200811059
Patrick LajoieJacky G. GoetzJames W. DennisIvan R. NabiLattices The Journal of cell biology185:381-385. doi : 10.1083/jcb.200811059 [2009]
Palash K. Dutta and Yonggang KeThe Beauty and Utility of DNA Origami
Wang P.Travis A. MeyerVictor Pan Chem . 2:359-382. doi : 10.1016/j.chempr.2017.02.009 [2017]
PROTEIN TYROSINE PHOSPHATASES : Structure and Function , Substrate Specificity , and Inhibitor Development
Zhang Z . Annual review of pharmacology and toxicology . 42:209. doi : 10.1146/annurev.pharmtox.42.083001.144616 [2002]
Oncogenic kinase signalling
Blume-Jensen P.Tony Hunter . NatureLondon ) . 411:355-365. doi : 10.1038/35077225 [2001]
O. Tolulope Okeowo and I. Olaposi Omotuyi
Metibemu D. S.O. Adeboye AkinloyeA. Jamiu AkamoD. Ajiboye Ojo Egyptian Journal of Medical Human Genetics20:1-16. doi : 10.1186/s43042-019-0035-0 [2019]
Nunez D., Costin Antonescu, Marcel Mettlen, Allen Liu, Sandra L. Schmid, Dinah Loerke and Gaudenz Danuser. (2011) Hotspots Organize Clathrin-Mediated Endocytosis by Efficient Recruitment and Retention of Nucleating Resources. Traffic (Copenhagen, Denmark). 12:1868-1878. doi: 10.1111/j.1600-0854.2011.01273.x
Nunez D.Costin AntonescuMarcel MettlenAllen LiuSandra L. SchmidDinah LoerkeGaudenz Danuser Traffic ( Copenhagen , Denmark ) . 12:1868-1878. doi : 10.1111/j.1600-0854.2011.01273.x [2011]
Nucleic acid junctions and lattices
Seeman N. C. Journal of theoretical biology99:237-247. doi : 10.1016/0022-5193 ( 82 ) 90002-9 [1982]
Nigel W. Bunnett and William C. Mobley
Grimes M. L.Jie ZhouEric C. BeattieEric C. YuenDeborah E. HallJanice S. VallettaKimberly S. ToppJennifer H. LaVail Journal of Neuroscience16:7950-7964. doi : 10.1523/JNEUROSCI.16-24-07950.1996 [1996]
Nida Iqbal and Naveed Iqbal. (2014) Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications. Molecular biology international. 2014:1-9. doi: 10.1155/2014/852748
Nida IqbalNaveed Iqbal Molecular biology international . 2014:1-9. doi : 10.1155/2014/852748 [2014]
Next-generation mTOR inhibitors in clinical oncology : how pathway complexity informs therapeutic strategy
Wander S. A.Bryan T. HennessyJoyce M. Slingerland The Journal of clinical investigation121:1231-1241. doi : 10.1172/jci44145 [2011]
Neurotrophins use the Erk5 pathway to mediate a retrograde survival response
Watson F. L.Heather M. HeerssenAnita BhattacharyyaLaura KlesseMichael Z. LinRosalind A. Segal Nature neuroscience4:981-988. doi : 10.1038/nn720 [2001]
Nanomaterials Based on DNA
Seeman N. C. Annual Review of Biochemistry79:65-87. doi : 10.1146/annurev-biochem-060308-102244 [2010]
N. J. Yoo and S. H. Lee
Kim M. S.E. G. Jeong British journal of cancer98:1533-1535. doi : 10.1038/sj.bjc.6604212 [2008]
N I Goldstein, M Prewett, K Zuklys, P Rockwell and J Mendelsohn. (1995) Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clinical Cancer Research. 1:1311.
N I GoldsteinM PrewettK ZuklysP RockwellJ Mendelsohn Clinical Cancer Research . 1:1311 [1995]
Mutant BRAF Melanomas ? Dependence and Resistance
Poulikakos P. I.Neal Rosen Cancer cell19:11-15. doi : 10.1016/j.ccr.2011.01.008 [2011]
Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
Cao Y . Trends in molecular medicine19:460-473. doi : 10.1016/j.molmed.2013.05.002 [2013]
Mostov K., Tao Su and Martin ter Beest. (2003) Polarized epithelial membrane traffic: conservation and plasticity. Nature cell biology. 5:287-293. doi: 10.1038/ncb0403-287
Mostov K.Tao SuMartin ter Beest Nature cell biology5:287-293. doi : 10.1038/ncb0403-287 [2003]
Moriki T., Hiroko Maruyama and Ichi N. Maruyama. (2001) Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. Journal of molecular biology. 311:1011-1026. doi: 10.1006/jmbi.2001.4923
Moriki T.Hiroko MaruyamaIchi N. Maruyama Journal of molecular biology311:1011-1026. doi : 10.1006/jmbi.2001.4923 [2001]
Montemurro F., Michela Donadio, Matteo Clavarezza, Stefania Redana, Maria Elena Jacomuzzi, Giorgio Valabrega, Saverio Danese, Guido Vietti-Ramus, Antonio Durando, Marco Venturini and Massimo Aglietta. (2006) Outcome of Patients with HER2-Positive Advanced Breast Cancer Progressing During Trastuzumab-Based Therapy. The Oncologist. 11:318-324. doi: 10.1634/theoncologist.11-4-318
Montemurro F.Michela DonadioMatteo ClavarezzaStefania RedanaElena JacomuzziGiorgio ValabregaSaverio DaneseGuido Vietti-RamusAntonio DurandoMarco VenturiniMassimo Aglietta The Oncologist . 11:318-324. doi : 10.1634/theoncologist.11-4-318 [2006]
Monte Carlo simulations of plasma membrane corral-induced EGFR clustering
Costa M. N.Krishnan RadhakrishnanJeremy S. Edwards Journal of biotechnology151:261-270. doi : 10.1016/j.jbiotec.2010.12.009 [2011]
Molecular mechanisms of lymphangiogenesis in health and disease
Alitalo K.Peter Carmeliet . Cancer cell1:219-227. doi : 10.1016/s1535-6108 ( 02 ) 00051-x [2002]
Molecular and cellular pathogenesis of melanoma initiation and progression
Regad T. Cell . Mol . Life Sci70:4055-4065. doi : 10.1007/s00018-013-1324-2 [2013]
Mitogen-Activated Protein ( MAP ) Kinase/MAP Kinase Phosphatase Regulation : Roles in Cell Growth , Death , and Cancer
Boutros T.Eric ChevetPeter Metrakos Pharmacological reviews60:261-310. doi : 10.1124/pr.107.00106 [2008]
Michael D. Ehlers, David R. Kaplan, Donald L. Price and Vassilis E. Koliatsos. (1995) NGF-Stimulated Retrograde Transport of trkA in the Mammalian Nervous System. The Journal of cell biology. 130:149-156. doi: 10.1083/jcb.130.1.149
Michael D. EhlersDavid R. KaplanDonald L. PriceVassilis E. Koliatsos The Journal of cell biology130:149-156. doi : 10.1083/jcb.130.1.149 [1995]
Metabolism considerations for kinase inhibitors in cancer treatment
Duckett D. R.Michael D. Cameron . Expert Opinion on Drug Metabolism & Toxicology . 6:1175- 1193. doi : 10.1517/17425255.2010.506873 [2010]
Messersmith W. A. and Dennis J. Ahnen. (2008) Targeting EGFR in Colorectal Cancer. The New England Journal of Medicine. 359:1834-1836. doi: 10.1056/NEJMe0806778
Messersmith W. A.Dennis J. Ahnen The New England Journal of Medicine359:1834-1836. doi : 10.1056/NEJMe0806778 [2008]
Mechanisms and functions of p38 MAPK signalling
Cuadrado A.Angel R Nebreda Biochemical journal429:403-417. doi : 10.1042/bj20100323 [2010]
McNiven M. A. (2006) Big gulps: specialized membrane domains for rapid receptor?mediated endocytosis. Trends in cell biology. 16:487-492. doi: 10.1016/j.tcb.2006.08.007
Maureen Murphy and Stanford J. Stewart
Debu TripathyDennis J. SlamonMelody CobleighAndrew ArnoldMansoor SalehJoanne E. Mortimer Journal of Clinical Oncology22:1063-1070. doi : 10.1200/JCO.2004.06.557 [2004]
Marie-Fran ? oise Heymann and Dominique Heymann
galiny A. I.Marta Tellez-Gabriel Journal of bone oncology4:1-12. doi : 10.1016/j.jbo.2015.01.001 [2015]
MAP kinase signalling pathways in cancerThe endocytic matrix
A. S.S. HaganO. RathW. Kolch Oncogene . 26:3279-3290. doi : 10.1038/sj.onc.1210421 Di Fiore P. P. and Giorgio ScitaNature . 463:464-473. doi : 10.1038/nature08910 [20072010]
MAP Kinase Pathways
Morrison D. K. Cold Spring Harbor perspectives in biology . 4 : a011254 . doi : 10.1101/cshperspect.a011254 [2012]
M ? kinen , Catherine D. Nobes. ( 2010 ) Ephrin-B2 controls
Wang, Masanori NakayamaMara E. PitulescuTim S. SchmidtMagdalena L., Akira, Susanne, Alice, Urban Deutsch ,L ?, Alcide BarberisLaura E. angiogenesislymphangiogenesis . Nature ( London [H.]
Ligand-induced activation of the insulin receptor : a multi-step process involving structural changes in both the ligand and the receptor
C. W.Michael C. Lawrence BioEssays . 31:422-434. doi : 10.1002/bies.200800210 [2009]
Ligand-induced ErbB receptor dimerization
Lemmon M. A . Experimental cell research315:638-648. doi : 10.1016/j.yexcr.2008.10.024 [2009]
Li E. and Kalina Hristova. (2010) Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics. Cell adhesion & migration. 4:249- 254.
Li E.Kalina Hristova Cell adhesion & migration . 4:249- 254 [2010]
Koul H. K., M. Pal and S. Koul. (2013) Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes & cancer. 4:342-359. doi: 10.1177/1947601913507951
Koul H. K.M. PalS. Koul Genes & cancer4:342-359. doi : 10.1177/1947601913507951 [2013]
Jänne P. A., James Chih-Hsin Yang, Dong-Wan Kim, David Planchard, Yuichiro Ohe, Suresh S. Ramalingam, Myung-Ju Ahn, Sang-We Kim, Wu-Chou Su, Leora Horn, Daniel Haggstrom, Enriqueta Felip, Joo-Hang Kim, Paul Frewer, Mireille Cantarini, Kathryn H. Brown, Paul A. Dickinson, Serban Ghiorghiu and Malcolm Ranson. (2015) AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer. The New England journal of medicine. 372:1689-1699. doi: 10.1056/nejmoa1411817
J ?P. A.James Chih-Hsin, Dong-Wan, David, Yuichiro, SureshRamalingam ,Ahn ,Kim ,Su , Leora, Daniel HaggstromEnriqueta FelipJoo-Hang Kim Ghiorghiu and Malcolm Ranson . ( 2015 ) AZD9291 in EGFR [Frewer]
John , N. Nogami , Y.
Ramalingam S.J. C. -H, C.Lee , T., D.Kim , Phase I expansion cohortsJournal of thoracic oncology . 11 : S152 . doi : 10.1016/S1556- [P.]
J. W. Gray and J. T. Groves
Salaita K.P. M. NairR. S. PetitR. M. NeveD. Das Science ( American Association for the Advancement of Science ) . 327:1380-1385. doi : 10.1126/science.1181729 [2010]
J ? rgen Cox , Pavankumar N. G. Reddy , Frank D. B ? hmerMatthias Mann and Hubert ServeMislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
Choudhary C.Jesper V. OlsenChristian BrandtsVolker GerkeDirk-E Schmidt-ArrasWolfgang E. BerdelCarsten M Molecular cell36:326-339. doi : 10.1016/j.molcel.2009.09.019 [2009]
Ioanna Bethani and Amparo Acker-PalmerSpatial organization of transmembrane receptor signalling
nland S. S.Ivan Dikic The EMBO Journal29:2677-2688. doi : 10.1038/emboj.2010.175 [2010]
Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer
Roberto IacovelliCora N. SternbergCamillo PortaElena VerzoniFilippo de BraudBernard EscudierGiuseppe Procopio A Systematic Review and Meta-Analysis . Current Drug Targets . 16:164-170. doi : 10.2174/1389450115666141120120145 [2015]
Inhibiting Signal Transduction : Recent Advances in the Development of Receptor Tyrosine Kinase and Ras Inhibitors
Hao D.Eric K. Rowinsky Cancer Investigation20:387-404. doi : 10.1081/CNV-120001184 [2002]
Ib ? ? ez
Paratcha G.Fernanda LeddaLouise BaarsMuriel CoulpierValerie BessetJonas AndersRizaldy ScottCarlos F NeuronCambridge , Mass. ) . 29:171-184. doi : 10.1016/S0896-6273 ( 01 ) 00188-X [2001]
I. D. Goldfine and R. Vigneri
Papa V.V. PezzinoA. CostantinoA. BelfioreD. GiuffridaL. FrittittaG. B. VannelliR. Brand The Journal of clinical investigation86:1503-1510. doi : 10.1172/jci114868 [1990]
Hui L., Kurt Zatloukal, Harald Scheuch, Ewa Stepniak and Erwin F. Wagner. (2008) Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. The Journal of clinical investigation. 118:3943- 3953. doi: 10.1172/jci37156
Hui L.Kurt ZatloukalHarald ScheuchEwa StepniakErwin F. Wagner The Journal of clinical investigation118:3943- 3953. doi : 10.1172/jci37156 [2008]
Hayashi M., Colleen Fearns, Brian Eliceiri, Young Yang and Jiing-Dwan Lee. (2005) Big Mitogen-Activated Protein Kinase 1/Extracellular Signal-Regulated Kinase 5 Signaling Pathway Is Essential for Tumor-Associated Angiogenesis. Cancer research (Chicago, Ill.). 65:7699-7706. doi: 10.1158/0008-5472.can-04-4540
Hayashi M.Colleen FearnsBrian EliceiriYoung YangJiing-Dwan Lee Cancer researchChicago , Ill. ) . 65:7699-7706. doi : 10.1158/0008-5472.can-04-4540 [2005]
Haber D., Nathanael S Gray and Jose Baselga. (2011) The Evolving War on Cancer. Cell (Cambridge). 145:19-24. doi: 10.1016/j.cell.2011.03.026
Haber D.Nathanael S GrayJose Baselga Cell ( Cambridge ) . 145:19-24. doi : 10.1016/j.cell.2011.03.026 [2011]
H. Beug and W. Mikulits
Gotzmann J.A. N. M. FischerM. ZojerM. MikulaV. ProellH. HuberM. JechlingerT. WaernerA. Weith Oncogene . 25:3170-3185. doi : 10.1038/sj.onc.1209083 [2006]
Grecco H., Malte Schmick and Philippe I H. Bastiaens. (2011) Signaling from the Living Plasma Membrane. Cell (Cambridge). 144:897-909. doi: 10.1016/j.cell.2011.01.029
Grecco H.Malte SchmickPhilippe I H. Bastiaens Cell ( Cambridge ) . 144:897-909. doi : 10.1016/j.cell.2011.01.029 [2011]
Graeme S. Cottrell and Nigel W. Bunnett
Jane E. MurphyBenjamin E. PadillaBurcu Hasdemir Proceedings of the National Academy of Sciences - PNAS . 106:17615-17622. doi : 10.1073/pnas.0906541106 [2009]
Folding DNA to create nanoscale shapes and patterns
P. W. K. Nature ( London ) . 440:297-302. doi : 10.1038/nature04586 [2006]
Exploring the function of the JNK ( c-Jun N-terminal kinase ) signalling pathway in physiological and pathological processes to design novel therapeutic strategies
Davies C.Cathy Tournier Biochemical Society transactions . 40:85-89. doi : 10.1042/BST20110641 [2012]
Evolution of protein kinase signaling from yeast to man
Manning G.Gregory D. PlowmanTony HunterSucha Sudarsanam Trends in biochemical sciences ( Amsterdam . Regular ed. ) . 27:514-520. doi : 10.1016/s0968-0004 ( 02 ) 02179-5 [2002]
Epidermal growth factor receptor in relation to tumor development : EGFR gene and cancer
Mitsudomi T.Yasushi Yatabe The FEBS journal277:301-308. doi : 10.1111/j.1742-4658.2009.07448.x [2010]
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Wee P.Zhixiang Wang Cancers . 9:52. doi : 10.3390/cancers9050052 [2017]
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Sawamiphak S.Sascha SeidelClara L. EssmannGeorge A. WilkinsonMara E. PitulescuTill AckerAmparo Acker-Palmer NatureLondon ) . 465:487-491. doi : 10.1038/nature08995 [2010]
Endocytosis and spatial restriction of cell signaling
Disanza A.Emanuela FrittoliAndrea PalamidessiGiorgio Scita Molecular oncology3:280-296. doi : 10.1016/j.molonc.2009.05.008 [2009]
Edouard C. Nice and Antony W. Burgess
A. H. A.Francesca WalkerSuzanne G. OrchardChristine HendersonDominik FuchsJulie Rothacker The Journal of biological chemistry280:30392-30399. doi : 10.1074/jbc.m504770200 [2005]
ERK5 and its role in tumour development
Lochhead P.Rebecca GilleySimon J Cook Biochemical Society transactions . 40:251-256. doi : 10.1042/bst20110663 [2012]
Douglas J. Zeckner , Greg Tucker-Kellogg , Jeffrey Touchman , Ketan Patel
D. ,L. FaberCandice HornGregory P. DonohoStephen L., ChristianeRobbins ,Hostetter ,Boguslawski ,Y. MosesStephanie Savage ,Uhlik , Aimin, Jian Du Spyro, Michael Bittner , Richard Schevitz , [Qian]
Distinct Roles for JNK1 and JNK2 in Regulating JNK Activity and c-Jun-Dependent Cell Proliferation
Sabapathy K.Konrad HochedlingerShin Yuen NamAnton BauerMichael KarinErwin F. Wagner Molecular cell15:713-725. doi : 10.1016/j.molcel.2004.08.028 [2004]
Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발
Derailed endocytosis : an emerging feature of cancer
Mosesson Y.Gordon B . MillsYosef Yarden Nature reviews . Cancer8:835-850. doi : 10.1038/nrc2521 [2008]
Couet J., M. Sargiacomo and M. P. Lisanti. (1997) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. The Journal of biological chemistry. 272:30429-30438. doi: 10.1074/jbc.272.48.30429
Couet J.M. SargiacomoM. P. Lisanti The Journal of biological chemistry272:30429-30438. doi : 10.1074/jbc.272.48.30429 [1997]
Coordinated protein sorting , targeting and distribution in polarized cells
Mellman I.W. James Nelson . Nature reviews . Molecular cell biology9:833-845. doi : 10.1038/nrm2525 [2008]
Co-mutations in EGFR driven non-small cell lung cancer
Rosell R.Niki Karachaliou EBioMedicine . 42:18-19. doi : 10.1016/j.ebiom.2019.03.037 [2019]
Chen N., Masaaki Nomura, Qing-Bai She, Wei-Ya Ma, Ann M. Bode, Linan Wang, Richard A. Flavell and Zigang Dong. (2001) Suppression of Skin Tumorigenesis in c-Jun NH2-Terminal Kinase-2-Deficient Mice. Cancer Research. 61:3908.
Chen N.Masaaki NomuraQing-Bai SheWei-Ya MaAnn M. BodeLinan WangRichard A. FlavellZigang Dong Cancer Research . 61:3908 [2001]
Cell Signaling by Receptor Tyrosine Kinases
Lemmon M. A.Joseph Schlessinger . Cell ( Cambridge ) . 141:1117-1134. doi : 10.1016/j.cell.2010.06.011 [2010]
Castro C. E., Fabian Kilchherr, Do-Nyun Kim, Enrique Lin Shiao, Tobias Wauer, Philipp Wortmann, Mark Bathe and Hendrik Dietz. (2011) A primer to scaffolded DNA origami. Nature methods. 8:221-229. doi: 10.1038/nmeth.1570
C. E.Fabian KilchherrDo-Nyun KimEnrique Lin ShiaoTobias WauerPhilipp WortmannMark BatheHendrik Dietz Nature methods8:221-229. doi : 10.1038/nmeth.1570 [2011]
Busyamas Chewaskulyong , Haiyi Jiang ,
S. ,Wu ,Thongprasert ,Yang ,Chu ,Saijo ,Sunpaweravong ,Han ,Margono ,Ichinose ,Nishiwaki , Yuichiro, Jin-Ji Yang Fukuoka . ( 2009 ) Gefitinib or Carboplatin ? Paclitaxel in [Duffield]
Bryant D. M. and Keith E. Mostov. (2008) From cells to organs: building polarized tissue. Nature reviews. Molecular cell biology. 9:887-901. doi: 10.1038/nrm2523
Bryant D. M.Keith E. Mostov Nature reviews . Molecular cell biology9:887-901. doi : 10.1038/nrm2523 [2008]
Brice Emanuelli and C. Ronald Kahn
Taniguchi C. M. Nature reviews . Molecular cell biology7:85-96. doi : 10.1038/nrm1837 [2006]
Brian P. Ceresa, Aimee W. Kao, Scott R. Santeler and Jeffrey E. Pessin. (1998) Inhibition of Clathrin-Mediated Endocytosis Selectively Attenuates Specific Insulin Receptor Signal Transduction Pathways. Molecular and Cellular Biology. 18:3862-3870. doi: 10.1128/MCB.18.7.3862
Brian P. CeresaAimee W. KaoScott R. SantelerJeffrey E. Pessin Molecular and Cellular Biology18:3862-3870. doi : 10.1128/MCB.18.7.3862 [1998]
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor
Kato Y.Richard I . TappingShuang HuangMark H. WatsonRichard J. UlevitchJiing-Dwan Lee NatureLondon ) . 395:713-716. doi : 10.1038/27234 [1998]
Blocking the mTOR pathway : a drug discovery perspective
Garcia-Echeverria C. Biochemical Society transactions . 39:451-455. doi : 10.1042/BST0390451 [2011]
Bart A. Westerman and Albert J. Kooistra
G. K.Chris de GraafIwan J. P. de EschRob LeursThomas W ? rdinger Trends in pharmacological sciences ( Regular ed. ) . 40:818-832. doi : 10.1016/j.tips.2019.09.002 [2019]
Banumathi K. Cole, Marcello Curto, Annie W. Chan and Andrea I. McClatchey. (2008) Localization to the Cortical Cytoskeleton Is Necessary for Nf2/Merlin-Dependent Epidermal Growth Factor Receptor Silencing. Molecular and Cellular Biology. 28:1274- 1284. doi: 10.1128/MCB.01139-07
K. ColeMarcello CurtoAnnie W. ChanAndrea I. McClatchey Molecular and Cellular Biology28:1274- 1284. doi : 10.1128/MCB.01139-07 [2008]
B. I. Posner and J. J. Bergeron
Di Guglielmo G. M.P. C. BaassW. J. Ou The EMBO journal13:4269-4277. doi : 10.1002/j.1460-2075.1994.tb06747.x [1994]
Angiogenesis as a therapeutic target
Ferrara N.Robert S. Kerbel NatureLondon ) . 438:967-974. doi : 10.1038/nature04483 [2005]
A. Karpov O., Gareth W. Fearnley, Gina A. Smith, Jayakanth Kankanala, Michael J. McPherson, Darren C. Tomlinson, Michael A. Harrison and Sreenivasan Ponnambalam. (2015) Receptor tyrosine kinase structure and function in health and disease. AIMS biophysics. 2:476-502. doi: 10.3934/biophy.2015.4.476
A. Karpov O.Gareth W. FearnleyGina A. SmithJayakanth KankanalaMichael J. McPhersonDarren C. TomlinsonMichael A. HarrisonSreenivasan Ponnambalam AIMS biophysics . 2:476-502. doi : 10.3934/biophy.2015.4.476 [2015]
A novel AKT3 mutation in melanoma tumours and cell lines
Davies M. A.K. Stemke-HaleC. TellezT. L. CalderoneW. DengV. G. PrietoA. J. F. LazarJ. E. GershenwaldG. B . Mills British journal of cancer99:1265-1268. doi : 10.1038/sj.bjc.6604637 [2008]
? nnePreexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Carly MurphySara AkhavanfardBeow Y. YeapYun XiaoMarzia CapellettiA. John IafrateCharles LeeJames G. ChristensenJeffrey A. EngelmanPasi A. J Cancer cell17:77-88. doi : 10.1016/j.ccr.2009.11.022 [2010]
1964 ) A mechanism for gene conversion in fungi
Holliday R. Genetical Research . 5:282- 304. doi : 10.1017/S0016672300001233
. doi : 10.1093/annonc/mds351 Engelman J .
J. Jassem .2012 )growth factor receptorEGFR )and derived. Annals of. 23 : R. G. Pestell and M.Lisanti [R.]
, X. Zhao , J. Christensen ,
Engelman. A.K. ZejnullahuT. Mitsudomi ,. Song ,Hyland ,O ., N., C. -M Lee , B. E. Johnson , L. C. Cantley and P. A. Janne . ( 2007 [,]
, Jaime Hughes , Vivian Kosmidou , Andrew
Davies H.Graham R. Bignell ,Cox , Philip, Sarah EdkinsSheila Clegg ,Teague , Hayley, Mathew J., William, Neil, Ed DicksRebecca EwingYvonne Floyd ,Gray , Sarah ,Mould , Adrian Parker , Claire Stevens [Rachel]
, Howard I. Scher and Mark X.
Agus D., Robert W., William D., Gail D., Brian, Paul I., Julie A., Charles, Douglas P., Krista . Cancer. 2:127-137. doi : 10.1016/s1535- 6108 ( 02 ) [(]

Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발

유사주제 논문( 124)

' Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발' 의 주제별 논문영향력

주제별 논문영향력

' Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발' 의 참고문헌

' Development of Novel Antibody-DNA Nanostructure Targeting Abnormal EGFR Signaling in Cancer Therapy = 항암치료에서 비정상적 EGFR 신호전달을 표적으로 하는 신규 항체-DNA 나노구조체 개발' 의 유사주제( ) 논문